COVID-19, thromboembolic risk and thromboprophylaxis: learning lessons from the bedside, awaiting evidence

Blood Transfus. 2020 May;18(3):226-229. doi: 10.2450/2020.0113-20.

Authors

Antonio Coppola¹, Maria Lombardi², Maria I Tassoni², Gaetano Carolla², Maurizio Tala³, Rossella Morandini³, Oriana Paoletti³, Sophie Testa³

Affiliations

¹ Regional Reference Center for Inherited Bleeding Disorders, University Hospital of Parma, Parma, Italy.
² Internal Medicine, Angiology and Coagulation Unit, University Hospital of Parma, Parma, Italy.
³ Haemostasis and Thrombosis Center, Cremona Hospital, Cremona, Italy.

No abstract available

Publication types

Comment

MeSH terms

Anticoagulants
Betacoronavirus
COVID-19
Coronavirus Infections
Coronavirus*
Humans
Pandemics
Pneumonia, Viral*
SARS-CoV-2

Substances

Anticoagulants